The Global HIV
Vaccine Enterprise
is an alliance of independent organizations around the world dedicated to accelerating the development of a preventive HIV vaccine by:
- Shared scientific plan: Implementing a strategic plan for HIV vaccine research that spans vaccine discovery, product development and manufacturing, and clinical trials
- Increased resources: Mobilizing significant new funding to achieve the scientific plan
- Greater collaboration: Promoting more efficient, faster ways for researchers to share successes and failures and avoid duplication of efforts
The Enterprise Approach
Work for
the Enterprise
Learn more in Careers
African AIDS Vaccine Program to Hold 5th International Forum on HIV Vaccine Development and Access in Kampala, Uganda – June 10, 2009
The African AIDS Vaccine Program (AAVP) will convene various stakeholders to promote the development of and future access to HIV vaccines suitable for use in Africa during their 5th international forum in Kampala, Uganda on December 13-15, 2009. This forum will serve as a platform for participants to share experiences and identify strategies to further unite African communities and scientists in HIV vaccine research and development. For more information about the AAVP 5th international forum, please visit the link below.
AAVP 5th international forum
Global HIV Vaccine Enterprise Holds Meeting of the Enterprise Coordinating Group to Prepare for the Release of HIV Vaccine Efficacy Trial Results (Coordinating Group) – June 3, 2009
The Global HIV Vaccine Enterprise hosted the meeting of the Enterprise Coordinating Group to discuss preparations for the release of the Prime Boost HIV Vaccine Phase III Trial (Thai trial). A summary of the June 3rd meeting of the Enterprise Coordinating Group can be found below.
Enterprise Coordinating Group Meeting Summary – June 3, 2009
Global HIV Vaccine Enterprise Holds Meeting of the Young and Early Career Investigators (YECI) Committee – May 19, 2009
The minutes from the May 19 meeting of the YECI Committee can be found below.
YECI Meeting Minutes - May 19, 2009
Global HIV Vaccine Enterprise Invites Participation in Upcoming HIV Vaccine Awareness Day Events – May 4, 2009
The Global HIV Vaccine Enterprise announced a list of events to commemorate HIV Vaccine Awareness Day on May 18, 2009. For more information, please visit the link below.
HIV Vaccine Awareness Day Events
Global HIV Vaccine Enterprise Council Members Recognized – May 4, 2009
Dr. Rafi Ahmed, an ex-officio member of the Global HIV Vaccine Enterprise (the Enterprise) Council, and Dr. Seth Berkley, a member of the Enterprise Council, were recognized last week for their contributions to the field of HIV vaccine research and development. Dr. Ahmed, Director of the Emory Vaccine Center and Emory University, who also serves as Chair of the Enterprise Science Committee, was chosen by the National Academy of Sciences as a new member of the Academy. Dr. Berkley, President and CEO of the International AIDS Vaccine Initiative (IAVI), was named one of Time Magazine’s “100 Most Influential People in the World.” For more information, please visit the links below.
Dr. Rafi Ahmed
Dr. Seth Berkley
More News from the Enterprise